End-to-end microbial solutions
for the recombinant production of proteins, plasmid DNA, and bioconjugates.
Accelerating your innovations through
bioprocess development and custom manufacturing.
ENGINEERING BIOLOGY
FROM START TO FINISH
enGenes Biotech is a CRO/CDMO
uniting microbial innovation with complete bioprocessing expertise.
Your competitive advantage
Unlock cost-efficient, scalable manufacturing for your target molecules with our E. coli-based technology platform. Achieve soluble expression of hard-to-express proteins using a growth-decoupled system, lower production costs through extracellular or continuous manufacturing, and accelerate your time-to-market with faster development.
Our expertise becomes your competitive advantage.
Some highlights
25 g/L
extracellular
Extracellular fed-batch process achieved record target protein titers of 25 g/L in under 3 months, starting from a mg/L intracellular process.
40 days
continuous
Fully continuous E. coli-based production of recombinant proteins and plasmid DNA, maintaining stable productivity for at least 40 days.
> 2 g/L
plasmid DNA
Tackled cost challenges in pDNA production by pushing yields over 2 g/L and reducing downstream unit operations while maintaining product quality.
Endonuclease
for scale
The price of our endonuclease eXrase enables DNA removal in industrial biotech fermentation processes, improving scalability, foam control, and downstream processing.
